Dimai H P, Hall S L, Stilt-Coffing B, Farley J R
Departments of Medicine and Biochemistry, Loma Linda University, and Research Service (151), Jerry L. Pettis Memorial Veterans Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA.
Calcif Tissue Int. 1998 Apr;62(4):309-15. doi: 10.1007/s002239900437.
The current studies were intended to assess dose- and time-dependent effects of dietary zinc (Zn) on alkaline phosphatase (ALP) activity and tartrate-resistant acid phosphatase (TRAP) activity in adult female mice. In the first study, mice were given 0, 1x, 2x, 3x, or 4x normal dietary Zn for 2 weeks, 4 weeks, or 6 weeks. In the second study, mice were given 0, 1x, 2x, 3x, 4x, and 5x normal dietary Zn for 4 weeks. Sera were collected for measurements of ALP and (in the second study) osteocalcin. Tibiae and calvaria were extracted for measurements of ALP, protein, and TRAP. The first study showed positive correlations between dietary Zn and serum ALP (4 and 6 weeks, P < 0.001), Zn and tibial ALP (2, 4, and 6 weeks, P < 0.03), and Zn and tibial protein (2, 4, and 6 weeks, P < 0.001), as well as a negative correlation between dietary Zn and tibial TRAP (2, 4, and 6 weeks, P < 0.001). Covariant analyses showed that serum ALP, tibial ALP, tibial protein, and tibial TRAP were affected by the dose of Zn (P < 0.005) and by the treatment time (P < 0.03). Supplemental studies showed that (1) the dose-dependent effect of dietary Zn on serum ALP (at 6 weeks) was proportional to the effects on tibial ALP and calvarial ALP, but not to the effects of Zn on renal, hepatic, or intestinal ALP; (2) 6 weeks of dietary Zn caused dose-dependent increases in ALP specific activity in the tibia, calvaria, and liver, but not kidneys or intestines; and (3) Zn increased ALP activity and cell layer protein and decreased TRAP activity in monolayer cultures of the murine osteoblastic cell line, MC3T3-E1. The second dietary study confirmed the results of the first: 4 weeks of treatment with Zn caused significant increases in serum ALP, calvarial ALP, and tibial ALP activities, and a significant decrease in tibial TRAP (P < 0.05-0.005 for each). This study also revealed an effect of Zn to increase serum osteocalcin (P < 0.03 at 2x normal Zn). Together, these data indicate that incremental increases in dietary Zn are associated with increases in ALP activity in serum and in bone. The effect of Zn to decrease TRAP activity in osteoblast-line cells precludes the interpretation of a Zn-dependent decrease in tibial TRAP activity as evidence of decreased bone resorption.
当前研究旨在评估成年雌性小鼠饮食锌(Zn)对碱性磷酸酶(ALP)活性和抗酒石酸酸性磷酸酶(TRAP)活性的剂量和时间依赖性影响。在第一项研究中,给小鼠分别喂食0、1倍、2倍、3倍或4倍正常饮食锌,持续2周、4周或6周。在第二项研究中,给小鼠分别喂食0、1倍、2倍、3倍、4倍和5倍正常饮食锌,持续4周。收集血清用于测量ALP以及(在第二项研究中)骨钙素。提取胫骨和颅骨用于测量ALP、蛋白质和TRAP。第一项研究显示饮食锌与血清ALP(4周和6周,P < 0.001)、锌与胫骨ALP(2周、4周和6周,P < 0.03)以及锌与胫骨蛋白质(2周、4周和6周,P < 0.001)之间呈正相关,同时饮食锌与胫骨TRAP(2周、4周和6周,P < 0.001)之间呈负相关。协方差分析表明血清ALP、胫骨ALP、胫骨蛋白质和胫骨TRAP受锌剂量(P < 0.005)和治疗时间(P < 0.03)的影响。补充研究表明:(1)饮食锌对血清ALP(6周时)的剂量依赖性影响与对胫骨ALP和颅骨ALP的影响成正比,但与锌对肾脏、肝脏或肠道ALP的影响不成正比;(2)6周的饮食锌导致胫骨、颅骨和肝脏中ALP比活性呈剂量依赖性增加,但肾脏和肠道未出现这种情况;(3)锌增加了小鼠成骨细胞系MC3T3 - E1单层培养物中的ALP活性和细胞层蛋白质,并降低了TRAP活性。第二项饮食研究证实了第一项研究的结果:锌处理4周导致血清ALP、颅骨ALP和胫骨ALP活性显著增加,胫骨TRAP显著降低(每项P < 0.05 - 0.005)。该研究还揭示了锌对增加血清骨钙素的作用(正常锌的2倍时P < 0.03)。总之,这些数据表明饮食锌的逐渐增加与血清和骨骼中ALP活性的增加相关。锌对成骨细胞系细胞中TRAP活性的降低作用,排除了将胫骨TRAP活性的锌依赖性降低解释为骨吸收减少证据的可能性。